Back

MATRIX trial - Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox

25 August 2018 (11:45 - 11:55)
Organised by:
Congress Presentation Part of: Late Breaking Science in Interventional Cardiology 1 Revascularisation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

12 More presentations in this session

Presentation thumbnail
Panel Discussants.
Video
Presentation thumbnail
FUTURE trial - Treatment strategy in multivessel coronary disease patients based on Fractional Flow Reserve
Professor G. Rioufol (Lyon, FR)
Slides Video
Presentation thumbnail
Panel discussion.
Video
Presentation thumbnail
TMVR Registry - Outcomes of Transcatheter Mitral Valve Replacement in Patients with Degenerated Bioprostheses, Failed Annuloplasty Rings and Severe Mitral Annular Calcification
Doctor S. Yoon (Hackensack, US)
Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Late Breaking Science in Interventional Cardiology 1

The Event

Event poster

ESC Congress 2018

25 August 2018 11:45 CET
You may be interested in
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
28 August 2023
thumbnail
Congress Presentation
Characterization and trends in acute aortic syndromes: a single centre 10 year-analysis
14 March 2025
thumbnail
Congress Presentation
Major adverse cardiac events in acute coronary syndrome patients with atrial fibrillation
1 July 2021
thumbnail
Congress Presentation
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources